Singapore-based provider of omnichannel customer engagement software, Acqueon, received investment from Long Ridge Partners. Existing investor Everstone Capital has exited its majority stake. It now holds a minority equity stake in Acqueon. The company announced the growth capital investment on October 25, 2022. However, the company did not disclose the amount of growth capital.

Purpose of investment by Acqueon 

With the latest capital injection, Acqueon intends to further extend its position via accelerated product innovation and channel partner expansion.

It also seeks continued investments in its people, platform, and client services. The investment follows a growth period for Acqueon, with more than 200 enterprise customers across financial services & banking, healthcare, retail & distribution and the public sector leveraging Acqueon’s platform to orchestrate and execute their omnichannel customer engagement strategies.

What the Acqueon official has to say

Ashish Koul, CEO of Acqueon Technologies Inc., said, “We are thrilled to partner with Long Ridge as we enter our next growth phase. We are incredibly proud of the world-class business Acqueon has become over the past several years and see tremendous opportunity ahead. With a focus on innovation, customer service, and partnership, we have been able to respond to evolving consumer demands and rapidly scale our client base. We look forward to working with Long Ridge and continuing to be the leader in proactive, trusted, and intelligent customer engagement technology.”

What the investors have to say

Avnish Mehra, Senior Managing Director and Co-Head, Private Equity at Everstone Capital, said, “We are delighted to welcome Long Ridge as a significant investor in Acqueon. We incubated Acqueon within one of our tech services businesses, and it has gained fabulous traction due to its technology, industry expertise and a great team led by Ashish. During its tenure as an investor, Everstone executed various value-creation initiatives in Acqueon, including professionalizing and institutionalizing the business, adding deep industry experience, enabling R&D and sales investments and facilitating partnerships with new-age cloud contact centre players. Overall, Everstone has built a robust tech portfolio over the last few years, including investments like Everise, Pharmeasy, Apexon, Omega Healthcare, Innoveo, Servion and Acqueon.”

In addition, Andrew Cedar, Principal at Long Ridge, said, “Across industries, antiquated customer engagement technology is a challenge to enterprises, making it difficult to react to shifting consumer preferences and growing compliance burdens. Acqueon offers a modern, omnichannel customer engagement platform that is compatible with existing contact centre technology and helps clients orchestrate effective, compliant customer engagement campaigns. The Company is well-positioned for continued growth. We are excited to partner with Ashish and Acqueon’s proven team as they expand their market leadership, innovate the platform, and continue to grow their impressive client base.”

 About the company

Ashish Koul 2005 launched the company. Acqueon’s Conversational Engagement platform enables proactive revenue generation and service for customer-obsessed companies. It orchestrates outbound and omnichannel campaigns across voice, messaging & email channels. More than 200 customers and 110,000 agents across industries use the company’s platform.

For more extensive analysis and Market Intelligence reports, feel free to approach us.

We try our best to fact-check and bring well-researched as well as non-plagiarized content to you. Please let us know

if there are any discrepancies in any of our published stories,

-how we can improve,

-what stories you would like us to cover as well as what information you are looking for, in the comments section below or through our contact form!

-We look forward to your feedback, and thank you for stopping by!

Next Article

Previous articleSwitzerland-based banking platform Arf raises USD 13 million in seed funding
Next article Netherlands-based Symeres acquires Exemplify Biopharma
Jasleen Bhatia works as a content writer for VCBay News. She is pursuing her final semester in Bachelor of Business Administration from IIPS, DAVV. Driven by her keen interest in entrepreneurship and finance, she writes business-related articles.

LEAVE A REPLY

Please enter your comment!
Please enter your name here